Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Diabetologia|February 3, 2009
Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patientsS T Knudsen, E Laugesen, K W Hansen, et al.
Archives of Physical Medicine and Rehabilitation|November 24, 1999
Follow-up study of individuals with high tetraplegia (C1-C4) 14 to 24 years postinjuryK M Hall, S T Knudsen, J Wright, et al.
Diabetes Care|November 28, 2002
Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathySøren T Knudsen, Toke Bek, Per L Poulsen, et al.
Diabetologia|July 24, 2002
Effects on heart rate variability of metoprolol supplementary to ongoing ACE-inhibitor treatment in Type I diabetic patients with abnormal albuminuriaE Ebbehøj, P L Poulsen, K W Hansen, et al.
Journal of Human Hypertension|March 11, 2011
Pulse pressure and systolic night-day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitusE Laugesen, N B Rossen, P L Poulsen, et al.
Journal of Internal Medicine|July 16, 2003
Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked studyS T Knudsen, T Bek, P Løgstrup Poulsen, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology|November 13, 2003
Impact of essential hypertension and diabetes mellitus on left ventricular systolic and diastolic performanceN H Andersen, S H Poulsen, K Helleberg, et al.
Journal of Thrombosis and Haemostasis : JTH|June 8, 2010
Characterization of canine coagulation factor VII and its complex formation with tissue factor: canine-human cross-species compatibilityT Knudsen, A T Kristensen, B B Sørensen, et al.
Gut|March 9, 2005
Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjectsT T Knudsen, S Thorsen, S A Jensen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 20, 2019
Clinical benefits of switching to insulin degludec irrespective of previous basal insulin therapy in people with Type 1 or Type 2 diabetes: evidence from a European, multicentre, retrospective, non-interventional study (EU-TREAT)S T Knudsen, A Lapolla, B Schultes, et al.
Pageof 14